This site is intended for health professionals only

Home > News > New combination diabetes treatment

Stethoscope and a syringe on a diabetes test

Published on 7 February 2007

Share this story:

RELATED ARTICLES

New combination diabetes treatment

teaser

Takeda Pharmaceuticals has announced that pioglitazone is now licensed for use in combination with insulin in type 2 diabetes mellitus patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance.

Most read

1

Oral vitamin A could become an alternative to isotretinoin for acne

2

Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan

3

Amino acids supplement reduces muscle wasting and improves gut function in critically ill

4

Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest

5

Launch of the new Hospital Pharmacy Europe Mobile App

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

Share this story:

RELATED ARTICLES

x